|
Information For:
|
Revision BulletinFenofibrate Capsules
In accordance with the Rules and Procedures of the 2005-2010 Council of Experts, the Monograph Development–Gastrointestinal, Renal, and Endocrine Expert Committee has revised the Fenofibrate Capsules Monograph. Using a flexible monograph approach, the alternative Assay preparation under the Assay and Test solution under the Related compounds are included in the monograph for the Capsules that meet the requirements of the Dissolution Test 2. The Identification test A is deleted, to address comments that the excipient matrix may interfere with the infrared spectrum of the analyte. The Fenofibrate Capsules Revision Bulletin supersedes the currently official monograph and will be incorporated into the USP 33–NF 28 Reissue. Should you have any questions, please contact Elena Gonikberg (301–816–8251 or . Download the Fenofibrate Capsules Monograph What's New
![]() USP recalled USP 33-NF 28 on Jan. 8, 2010. A reissue product will be available in April 2010.
PF 36(2), March-April 2010: IRAs and Errata (03/01/10) February Revision Bulletins (02/26/10) Protamine Monographs: Notice of Intent to Revise (02/26/10) New Draft Pending Standard for the month of February (02/26/10) PF 36(2), March-April 2010: Highlights (02/22/10) Calculation Tool for the Performance Verification Test (PVT) of Dissolution Assemblies (02/22/10) Performance of Equipment to Test Dissolution of Medications Further Assured (02/09/10) New Official Text (01/29/10) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||